Efficacy of Ritlecitinib (PF-06651600) in Patients With Alopecia Totalis and Alopecia Universalis: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 6, p. s102, 2022. DOI: 10.25251/skin.6.supp.102. Disponível em: https://skin.dermsquared.com/skin/article/view/1861. Acesso em: 13 may. 2026.